Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Rocz Akad Med Bialymst ; 42 Suppl 1: 287-96, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9337546

RESUMO

Aberrant angiogenesis-the new vessels formation is a mandatory event in the process of tumor growth and expansion. Studies on mechanisms involved in tumor-induced angiogenesis (TIA) and on its possible inhibitors are needed in order to introduce in future new methods of tumor treatment. The aim of our study was to determine the usefulness of the modified cutaneous TIA (mice without immunosuppression) test for screening in vivo of the angiogenesis modifiers. In both models (classical and modified TIA) we demonstrated comparable angiogenesis activity following human lung cells inoculation and similar degree of neovascularization response inhibition caused by theobromine. We reported that in modified TIA model preincubation with theobromine significantly suppressed angiogenic potential of human lung cancer cells as well as the ability of those cells to produce proangiogenic cytokine-bFGF.


Assuntos
Adenocarcinoma/irrigação sanguínea , Antineoplásicos Fitogênicos/uso terapêutico , Carcinoma de Células Escamosas/irrigação sanguínea , Fator 2 de Crescimento de Fibroblastos/metabolismo , Neoplasias Pulmonares/irrigação sanguínea , Proteínas de Neoplasias/metabolismo , Neovascularização Patológica/tratamento farmacológico , Teobromina/uso terapêutico , Adenocarcinoma/tratamento farmacológico , Adenocarcinoma/metabolismo , Adenocarcinoma/patologia , Idoso , Animais , Antineoplásicos Fitogênicos/farmacologia , Carcinoma de Células Escamosas/tratamento farmacológico , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patologia , Ensaios de Seleção de Medicamentos Antitumorais , Feminino , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/patologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Pessoa de Meia-Idade , Transplante de Neoplasias , Células-Tronco Neoplásicas/efeitos dos fármacos , Cavidade Peritoneal , Taxa Secretória/efeitos dos fármacos , Teobromina/farmacologia
2.
Pol Merkur Lekarski ; 3(17): 231-3, 1997 Nov.
Artigo em Polonês | MEDLINE | ID: mdl-9523479

RESUMO

Streptococcus pneumoniae strains are exhibiting increasing rates of antibiotics resistance. A rapid increase of resistance was seen not only to penicillin but also other antimicrobial agents and therefore this paper describes the study of resistance and multiresistance of pneumococci to 7 antibiotics: penicillin (P), erythromycin (E), clindamycin (CC), tetracycline (T), co-trimoxazole (SXT), cefotaxime (CTX) and vancomycin (Va), using the disk-diffusion technique according to NCCLS procedure. We tested a total of 218 S. pneumoniae strains isolated from various materials: from sputum (54), noses (117), throats (28) and different swabs specimens (19). The overall percentage of resistant isolates to penicillin was 3.7%, to erythromycin--4.1%, to clindamycin--10.6%, to tetracycline--17.4%, to co-trimoxazole--15.6%, to cefotaxime--2.3%. In the sputum was most the monoresistant strains (66.7%). The multiresistance was highest in the penicillin resistant pneumococci. With the exception of vancomycin, the number of resistant strains to non-beta-lactam antibiotics (erythromycin, clindamycin, tetracycline, co-trimoxazole) was higher in penicillin-resistant strains compared with penicillin susceptible isolates. All isolates were susceptible to vancomycin.


Assuntos
Streptococcus pneumoniae/classificação , Streptococcus pneumoniae/efeitos dos fármacos , Adulto , Cefotaxima/farmacologia , Criança , Clindamicina/farmacologia , Resistência Microbiana a Medicamentos , Eritromicina/farmacologia , Feminino , Humanos , Masculino , Nariz/microbiologia , Resistência às Penicilinas , Faringe/microbiologia , Especificidade da Espécie , Escarro/microbiologia , Tetraciclina/farmacologia , Combinação Trimetoprima e Sulfametoxazol/farmacologia , Vancomicina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA